Back to BlackRock, Inc. BlackRock, Inc.

DSGNDSGN
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in DESIGN THERAPEUTICS INC

BlackRock, Inc. holds 2.7M shares of DSGN (DESIGN THERAPEUTICS INC), worth $38.5M as of 2026-Q2. The position was increased (+24.7% shares). DSGN represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$38.5M

Current Shares

2.7M

Total Value Change

+$22.6M

Total Shares Change

+80,425

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.7M
+24.7%
$38.5M0.0%$14.47
36
2026-Q1
Increased
2.1M
+0.8%
$22.7M0.0%$10.00
29
2025-Q4
Increased
2.1M
+3.6%
$19.9M0.0%$9.79
29
2025-Q3
Decreased
2M
-14.7%
$15.4M0.0%$6.85
0
2025-Q2
Decreased
2.4M
-3.4%
$8.1M0.0%$3.57
0
2025-Q1
Decreased
2.5M
-3.9%
$9.6M0.0%$4.21
0
2024-Q4
New
2.6M
-
$15.9M0.0%$6.17
39

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used